Loading...
XSHE
002172
Market cap647mUSD
Oct 09, Last price  
5.91CNY
1D
4.42%
1Q
98.99%
Jan 2017
-42.23%
IPO
-51.76%
Name

Jiangsu Aoyang Health Industry Co Ltd

Chart & performance

D1W1MN
XSHE:002172 chart
P/E
109.60
P/S
2.50
EPS
0.05
Div yield, %
—
Shrs. gr., 5y
-1.50%
Rev. gr., 5y
4.80%
Revenues
1.81b
-10.10%
1,634,642,4282,340,465,8443,805,268,6453,823,992,5583,552,361,5403,277,439,6784,676,187,8513,808,778,5934,875,817,8325,371,628,7944,710,672,8752,982,034,9511,885,102,4313,028,918,8111,429,370,6692,021,311,3172,021,311,3162,173,767,5652,009,775,2371,806,837,366
Net income
41m
+1.80%
0161,105,804100,458,230035,652,82320,912,535-71,923,162135,862,296259,242,231153,504,53610,359,790-425,175,242-458,994,2210-1,038,913,8740-15,365,74249,681,63140,561,92041,291,338
CFO
13m
+2,777.09%
56,235,5520320,511,918184,258,82700544,264,366238,730,309494,924,498334,683,988555,087,08599,606,13200125,329,1790054,303,048438,65112,620,384
Dividend
Apr 17, 20080.15 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Jiangsu Aoyang Health Industry Co.ltd. is a multifaceted enterprise primarily engaged in two key sectors: chemical fiber manufacturing and healthcare services. Globally, the company manufactures and distributes a range of chemical fibers, including advanced functional fibers and traditional viscose varieties. Complementing its industrial activities, Aoyang Health maintains a significant presence in the health sector. This includes the operation of hospitals, rehabilitation facilities, and retail pharmaceutical outlets. Furthermore, its healthcare portfolio extends to offering comprehensive health management solutions, managing pharmaceutical logistics, and distributing medical products. Established in 2001 and headquartered in Zhangjiagang, China, the entity underwent a name change in September 2018, transitioning from its previous designation, Jiangsu Aoyang Technology Corporation Limited, to its current identity.

Key people

Jing Li
General Manager · since 2025
Xiao Wang
Chief Financial Officer, Deputy General Manager · since 2025
Wei Wang
Deputy General Manager · since 2020
Zhihao Zhu
Deputy General Manager · since 2025
Chao Ji
Secretary of the Board, Director · since 2019
Yan Gao
Chairman of the Board · since 2025
Ping Lu
Director · since 2025
Vice Chairman of the Board · since 2025
Ye Shen
Deputy General Manager, Staff Elected Director · since 2025
Guoping Xi
Director · since 2025
Tingting Ni
Independent Director · since 2025
Zhuoya Sun
Independent Director · since 2025
Xiaojun Wu
Independent Director · since 2024
IPO date
Sep 21, 2007
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122023‑002022‑122022‑002021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT